Parfitian priority, gene therapy and disability
<p>Gene therapies for severe genetic disease are often highly expensive. In deciding whether or when to provide them, one ethical consideration is the benefit of treatment, relative to cost. But a separate consideration is concern for medical need, and the desire to benefit those who are worse...
| Egile nagusia: | |
|---|---|
| Formatua: | Journal article |
| Hizkuntza: | English |
| Argitaratua: |
Oxford University Press
2024
|